Hormones, mood, and cognitive functioning in postmenopausal women

Obstetrics and Gynecology

Volumn 87, Issue 2 II SUPPL., 1996, Pages

  Sherwin, Barbara B ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; LYNESTRENOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PIPERAZINE ESTRONE SULFATE;

ABDOMINAL HYSTERECTOMY; ALZHEIMER DISEASE; BRAIN FUNCTION; COGNITION; DEPRESSION; DROWSINESS; DRUG MIXTURE; DYSPHORIA; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; MEMORY; MOOD; POSTMENOPAUSE; PRIORITY JOURNAL; REM SLEEP; REVIEW; SALPINGOOOPHORECTOMY; SUBCUTANEOUS DRUG ADMINISTRATION; VERTIGO;

EID: 0030065485     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00431-9     Document Type: Article

References (39)

1. McEwen BS. The brain as a target organ of endocrine hormones. In: Kreiger DT, Hughes JS, eds. Neuroendocrinology. Sunderland: Sinauer Assoc, 1980.
2. Luine VN, McEwen BS. Effect of estradiol on turnover of type A monoamine oxidase in brain. J Neurochem 1977;28:1221-7.
3. Aylward M. Plasma tryptophan levels and mental depression in postmenopausal subjects: Effects of oral piperazine-oestrone sulphate. IRCS Med Sci 1973;1:30-4.
4. 3H-imipramine binding site in surgically menopausal women. Biol Psychiatry 1990;28:339-48.
5. Holzbauer M. Physiological aspects of steroids with anesthetic properties. Med Biol 1976;54:227-42.
6. Merryman W, Boidman R, Barnes K, Rothchild I. Progesterone "anesthesia" in human subjects. J Clin Endocrinol Metab 1954;14: 1567-9.
7. Halozbauer M, Yondin MBH. The oestrous cycle and monoamine oxidase activity. Br J Pharmacol 1973;48:600-8.
8. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendocrinology 1985;10:325-35.
9. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988;14:177-87.
10. Schneider MA, Brotherton PL, Hailles J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust 1977;2:162-70.
11. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological functioning in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-5.
12. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depression in women. Arch Gen Psychiatry 1979;36:742-4.
13. Palinkas LA, Barrett-Conner E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992;80:30-6.
14. Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JWW. The effects of norethisterone in menopausal women on oestrogen replacement therapy: A model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290-6.
15. Holst J, Backström T, Hammerbäch S, von Schoultz B. Progestogen addiction during oestrogen replacement therapy - effects of vasomotor symptoms and mood. Maturitas 1989;11:13-9.
16. Dennerstein L, Burrows GD, Hyman G, Sharpe K. Hormone therapy and affect. Maturitas 1979;1:247-54.
17. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behaviour in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-43.
18. Pfaff DW. Estrogen and brain function. New York: Springer-Verlag, 1980.
19. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of memory dysfunction. Science 1982;217:208-417.
20. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-91.
21. Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuations in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035-9.
22. Baddeley AD, Warrington EK. Amnesia and distinction between long-and short-term memory. J Verb Learning Verb Behav 1970; 9:176-89.
23. Jarvik LF. Human intelligence: Sex differences. Acta Genet Med Gemellol (Roma) 1975;24:189-211.
24. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4:31-47.
25. Hackman BW, Galbraith D. Six month study of oestrogen therapy with piperazine oestrone sulphate and its effects on memory. Curr Med Res Opin 1977;4:21-7.
26. Fedor-Freybergh P. The influence of oestrogen on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 1977;64:5-69.
27. Rauramo L, Langerspetz K, Engelom P, Punnonen R. The effect of castration and peronal estrogen therapy on some psychological functions. Front Horm Res 1975;8:133-51.
28. Vanhulle R, Demol R. A double-blind study of the influence of estriol on a number of psychological tests in post-menopausal women. In: Keep PA, Greenblatt RB, Albeaux-Ferner M, eds. Consensus on menopausal research. London: MTP Press, 1976: 94-9.
29. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;10:325-35.
30. Sherwin BB, Phillips S. Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 1990;592:474-5.
31. Phillips S, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1991; 17:485-95.
32. Ditkoff EC, Gary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-5.
33. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;260:2637-41.
34. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994;83:979-83.
35. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-79.
36. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women. Arch Neurol 1994;51:896-900.
37. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.
38. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986;11:337-45.
39. Honjo H, Ogino Y, Naithoh K, et al. In vivo effects by estrone sulphate on the central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 1989;34:521-5.